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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYOrgan formation and regeneration require epithelial progenitor expansion to engineer, maintain, and repair the branched tissue archi-
tecture. Identifying the mechanisms that control progenitor expansion will inform therapeutic organ (re)generation. Here, we discover
that combined KIT and fibroblast growth factor receptor 2b (FGFR2b) signaling specifically increases distal progenitor expansion during
salivary gland organogenesis. FGFR2b signaling upregulates the epithelial KIT pathway so that combined KIT/FGFR2b signaling, via sepa-
rate AKT and mitogen-activated protein kinase (MAPK) pathways, amplifies FGFR2b-dependent transcription. Combined KIT/FGFR2b
signaling selectively expands the number of KIT+K14+SOX10+ distal progenitors, and a genetic loss of KIT signaling depletes the distal
progenitors but also unexpectedly depletes the K5+ proximal progenitors. This occurs because the distal progenitors produce neurotro-
phic factors that support gland innervation, whichmaintains the proximal progenitors. Furthermore, a rare population of KIT+FGFR2b+
cells is present in adult glands, in which KIT signaling also regulates epithelial-neuronal communication during homeostasis. Our find-
ings provide a framework to direct regeneration of branched epithelial organs.INTRODUCTION
During organogenesis, epithelial progenitor cells generate
the branched architecture of the tissue. These progenitors
must increase in number while retaining their progenitor
qualities, in a process known as expansion. Organogenesis
further involves communication between expanding pro-
genitors and other cell types located in the niche or local
microenvironment (Wagers, 2012). Stromal, endothelial,
and neuronal cells provide external cues that control the
number of progenitors and their survival, maintenance,
and differentiation (Kiger et al., 2000; Knox et al., 2010;
Shen et al., 2004). Thus, it is imperative to understand the
mechanisms by which progenitors expand and how they
communicate with other cell types in order to regenerate
or reengineer thebranchedarchitecture of epithelial organs.
KIT (C-KIT, CD117), a receptor tyrosine kinase (RTK), has
been studied extensively in hematopoietic progenitors
(Kent et al., 2008), but less is known about its function in
epithelial progenitors. The ligand for KIT is stem cell factor
(SCF), the gene product of Kitl. KIT signals via numerous
pathways, including phosphatidylinositol 3-kinase (PI3K),
phospholipaseCg (PLCg),mitogen-activatedproteinkinase
(MAPK), and Janus kinase/Signal Transducer and Activator
of Transcription (JAK/STAT) (Lemmon and Schlessinger,
2010), and can transactivate other receptors (Jahn et al.,
2007; Wu et al., 1995). Importantly, KIT-expressing (KIT+)604 Stem Cell Reports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 Theprogenitors form and regenerate various epithelial organs.
Prostate tissue can be generated from a single KIT+ cell
(Leong et al., 2008), epithelial-specific KIT+ progenitors
functionally regenerate irradiated salivary glands (Lombaert
et al., 2008; Nanduri et al., 2013), and KIT+ cells repair lungs
postthoracotomy (Kajstura et al., 2011). These findings sug-
gest that epithelial KIT+ progenitors somehow lay the foun-
dation for branching organ architecture. Importantly, the
loss of KIT signaling due to a homozygous SNP (Chabot
et al., 1988), KitW/W, is lethal by embryonic day 14 (E14)
due to hematopoietic defects, but the effects of this muta-
tiononepithelialprogenitorsandorganogenesis areunclear.
Severe defects in epithelial organogenesis occur in mice
lacking Fgf10 or its receptor, Fgfr2b, and provide valuable
insight into epithelial progenitor cell biology. Many or-
gans, such as the salivary glands and lungs, do not form
or are hypoplastic (De Moerlooze et al., 2000; Ohuchi
et al., 2000). These phenotypes suggest defects in the
survival, maintenance, and/or expansion of epithelial pro-
genitors. In addition, mutations in fibroblast growth factor
receptor 2 (FGFR2) and KIT occur in many epithelial tu-
mors, and both receptors are being targeted with specific
RTK inhibitors in breast, lung, liver, salivary gland, skin,
renal, gastrointestinal, colorectal, ovarian, and uterine can-
cers (Casaletto andMcClatchey, 2012; Hanahan andWein-
berg, 2011; Lemmon and Schlessinger, 2010; Takeuchi and
Ito, 2011). We thus hypothesized that an interactionAuthors
Figure 1. Kit and Kitl Increase during Branching Morphogenesis, and KIT+ Progenitor Expansion Occurs in Endbuds
(A) qPCR analysis of Kit and Kitl mRNA expression during SMG development. Mean ± SEM, n > 3 biological SMGs at each developmental
stage. Data were normalized to Rps29 and E11.5 SMG.
(B) E14 SMGs. Whole-mount in situ analysis of Kit and Kitl mRNA expression, sections stained with Nuclear Fast Red. Black dashed lines
outline epithelia. Scale bars, 200 mm for whole mounts and 25 mm for sections.
(C) Staining of E13 and E16 SMGs for KIT, ECAD, and basement membrane (Perlecan [PLN]). Images are 1 mm confocal sections. Arrow
indicates endbuds. Scale bars, 20 mm.
(D) FACS analysis (% of cells/SMG) of ECAD+KIT+ cells during development. Data are mean ± SEM, n > 3 biological independent samples at
each developmental stage.
(E) KIT and Ki67 staining of E13 and E16 SMG endbuds. FACS analysis of E13 SMG showing the percentage of proliferating cells (Ki67+) in
KIT or KIT+ cells. Scale bar, 20 mm; n > 3 biological samples.
See also Figure S1.
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KIT/FGFR2b in Salivary Glandsbetween FGFR2b and KIT signaling could regulate epithe-
lial progenitor expansion during organogenesis.
To investigate this hypothesis, we studied mouse sub-
mandibular glands (SMGs), which develop by reiterative
rounds of distal endbud and proximal duct formation,
and require communication with the neuronal niche
(Knox et al., 2010). We discovered that FGFR2b signaling
upregulates the epithelial KIT pathway so that combined
KIT/FGFR2b signaling, via separate AKT and MAPK path-
ways, amplifies FGFR2b-dependent transcription. The
combined KIT and FGFR2b signaling increases the number
of KIT+FGFR2b+ distal progenitors, but loss of KITsignaling
depletes these progenitors. This KIT/FGFR2b-dependent
mechanism is conserved during adult tissue homeostasis
and in other branching organs.RESULTS
KIT+ Progenitor Expansion Occurs in Endbuds during
SMG Branching Morphogenesis
We first investigated the developmental expression and
localization of Kit and Kitl mRNA by quantitative PCRStem Cell R(qPCR; Figure 1A), in situ hybridization (Figure 1B), andmi-
croarray during development (Figure S1A available online).
mRNA products of both Kit and Kitlwere detectable during
gland initiation at E11.5, when the initial endbud forms
distal to a primary duct, and expression of both peaked at
E15 (Figure 1A). From E12 to E15, branching morpho-
genesis occurred with reiterative rounds of distal endbud
expansion and proximal duct formation. Whereas Kit
mRNA was localized to endbuds, Kitl mRNA was found
mainly in the mesenchyme around the endbuds, but was
also detected within endbuds (Figure 1B), as confirmed by
qPCR analysis of isolated E13 endbuds, ducts, and mesen-
chyme (Figure S1B). During branching morphogenesis,
KIT protein was localized to E-cadherin+ (ECAD+) endbud
cells (Figure 1C, E16, arrows), but was not detected in ducts
(KIT) (Figures 1B and 1C). Fluorescence-activated cell
sorting (FACS) analysis confirmed that during the rapid
branching phase, the number of epithelial KIT+ cells
(ECAD+KIT+) increased from 10% to 20% of total cells in
the intact SMG (Figures 1D and S1C). Furthermore, FACS
analysis and Ki67 staining showed that E13 ECAD+KIT+
cells were highly proliferative (Figure 1E), since 70%
of cycling SMG cells (Ki67+) were KIT+. This highlyeports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 The Authors 605
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KIT/FGFR2b in Salivary Glandsproliferative state occurred up to E16 (Figure 1E). By the
time secretory differentiation began after E16, both Kit
and Kitl mRNA expression decreased (Figures 1A and
S1A). KIT+ cells accounted for only 3% of total cells at
postnatal day 1 (P1; Figure 1D), which is comparable to
levels in adult SMGs (Lombaert et al., 2008). Since the
number of KIT+ endbud cells increases during branching
morphogenesis, the data suggest that KIT+ progenitor
expansion occurs in endbuds.
FGFR2b Signaling Upregulates an Autocrine Epithelial
KIT Pathway
FGFR2b signaling is essential for the survival and prolifer-
ation of epithelial endbuds; however, it is unclear whether
it regulates progenitor expansion. Since KITmarks the end-
bud progenitors, we hypothesized that FGFR2b signaling
controls KIT+ progenitor expansion by regulating KIT
function. We tested this by culturing isolated SMG
epithelia for 2 hr with inhibitors of FGFR (SU5402 [SU]),
MAPK (UO126), PI3K (LY29052) and PLCg (U7312), and
FGFR2b ligands and measuring downstream gene expres-
sion. Kitl was rapidly downregulated with SU or UO126
(Figure 2A). In contrast, addition of the FGFR2b ligands
FGF1, FGF7, and FGF10 specifically upregulated Kitl (Fig-
ure 2B), whereas other factors, such as FGF2, FGF8b,
BMP2, BMP4, BMP7, insulin growth factor 2 (IGF2), trans-
forming growth factor b1 (TGFb1), TGFb2, carbachol
(CCh), heparin-binding EGF-like growth factor (HBEGF),
and SCF, did not. In addition, Kitwas upregulated 6 hr after
FGF10 addition (Figure 2C). Thus, FGFR2b signaling posi-
tively regulates Kitl expression in the epithelium, which
may result in an autocrine activation of KIT in the endbud
progenitors by epithelial SCF.
FGFR2b and KIT Signal via Separate MAPK and AKT
Pathways
Because FGFR2b signaling may upregulate an autocrine
epithelial KIT pathway, we investigated the molecular in-
teractions of these pathways and paracrine KIT signaling
using cell lines expressing KIT and FGFR2b, and isolated
SMG epithelium. We were unable to coimmunoprecipitate
FGFR2b and KIT from SMG epithelium (not shown). Since
we could not show a direct interaction, we investigated
possible transactivation or signaling crosstalk on two
levels. First, at the ligand level, we used a rat myoblast
cell line (L6) expressing either Flag-tagged FGFR2b
(FGFR2b-FL) or hemagglutinin (HA)-tagged KIT (KIT-HA)
to show that the ligands are specific and do not phosphor-
ylate (Anti-PY) the other receptor in these cells (Figure 2D).
Second, at the receptor level, we used L6 cells expressing
both receptors (KIT+FGFR2b+L6) to show that KIT and
FGFR2b do not transactivate (Anti-PY) each other (Fig-
ure 2E). We then used FGFR2b+L6 or KIT+L6 cells to606 Stem Cell Reports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 Theshow that pERK1/2 is downstreamof bothKITand FGFR2b,
and that the KIT inhibitor ISCK03 (ISCK) specifically
reduced SCF/KIT-dependent pERK1/2, whereas SU specif-
ically reduced pERK12 downstream of FGF10/FGFR2b (Fig-
ure 2F). We confirmed that ISCK specifically inhibited KIT,
but not FGFR2b, phosphorylation (Figure S2A). Further, we
used a KIT+ human leukemic cell line, Mo7e, which does
not express FGFR2b, to confirm that SU did not inhibit
SCF-dependent pKITY721 and downstream pAKT, whereas
ISCK did (Figure S2B). Neither inhibitor reduced pERK1/2,
which is downstream of other RTKs in Mo7e cells. Taken
together, these data suggest that FGFR2b and KIT do
not transactivate each other, and that separate MAPK
and AKT signaling pathways occur downstream of each
receptor.
We also measured phosphorylation of KITY721 in isolated
SMG epithelia cultured for 24 hr with FGF10 and then
treated for 15 min with additional SCF or FGF10 and/or
SU and ISCK. There was a robust baseline level of pKITY721,
and SCF further increased pKITY721 and pAKT, whereas
FGF10 increased pERK1/2 (Figure 2G). As expected, SU
reduced pERK1/2 downstream of FGF10, and ISCK reduced
pAKT downstream of SCF. Exogenous FGF10 also increased
pKITY721, which is likely due to endogenous epithelial SCF
(i.e., autocrine KIT signaling in the epithelium) being
enhanced by FGF10. This FGF10-dependent pKITY721 and
pAKT were reduced by SU or SU+ISCK, suggesting that
in SMG epithelia, FGF10 may transactivate KIT or that SU
inhibits another receptor that transactivates KIT. We also
show that ISCK reduced pKITY721 and pAKT to near control
levels after SCF treatment and partially reduced pKITY721
after FGF10 treatment. In other experiments, ISCKwas spe-
cific and did not reduce pERK1/2 or pAKT downstream of
FGFR2b (with FGF10), epidermal growth factor receptor
(EGFR; with HBEGF), or FGFR1 receptors (with FGF2) after
1 hr (Figures S2C and S2D). These data suggest that separate
KIT and FGFR2b signaling occurs in SMG epithelia KIT+
progenitors.
Combined FGFR2b and KIT Signaling Amplifies
FGFR2b-Dependent Transcription
To investigate how separate KIT and FGFR2b signaling
pathways regulate progenitor expansion, we treated iso-
lated SMG epithelia with SCF and FGF10 alone or in com-
bination. The downstream phosphorylation with SCF
and FGF10 was additive and led to enhanced and sustained
phosphorylation of SHP2, AKT, and ERK1/2 comparedwith
either SCF or FGF10 alone (Figure 3A). We predicted that
this might increase downstream gene transcription. Thus,
we measured the expression of a cassette of transcription
factors (TFs), Sox10, Myc, Etv4, Etv5, and DNp63, all of
which are expressed in endbuds and potentially involved
in SMG progenitor expansion (Lombaert et al., 2011).Authors
Figure 2. FGFR2b Signaling Upregulates the Autocrine Epithelial KIT Pathway, and the Receptors Signal via Separate MAPK and AKT
Pathways
(A) qPCR analysis of Kitl and Kit in E13 epithelia 2 hr after addition of FGF10 and inhibitors: Control (DMSO), FGFR (SU5402), MAPK
(UO126), PI3K (LY29052), and PLCg (U7312). Data are mean ± SEM, normalized to Rsp29 and Control. One-way ANOVA with post-hoc
Dunnett’s test; ***p < 0.001, n = 3 biological samples.
(B) qPCR analysis of E13 epithelia 2 hr after growth factor addition. Data are mean ± SEM, normalized to Rsp29 and epithelia at 0 hr
(dashed line). Unpaired t test; *p < 0.05, n = 3 biological samples.
(C) qPCR analysis of E13 epithelia at different times after FGF10 treatment. Data are mean ± SEM, normalized to Rsp29 and 0 hr (gray
dashed line), n = 3 biological samples.
(D) Immunoblot for p-tyrosine kinase (PY), FGFR2 (Anti-Bek), and KIT (Anti-HA) after immunoprecipitation (IP) of FGFR2b-FL- or KIT-HA-
tagged proteins from FGFR2b+L6 or KIT+L6 cells 15 min after growth factor stimulation with either FGF10 or SCF.
(E) Immunoblot of phosphotyrosine (PY) and FGFR2 (Bek), and KIT (HA) after IP of Flag-FGFR2b or HA-KIT in KIT+FGFR2b+ L6 cells, after
FGF10, SCF, and/or ISCK treatment.
(F) Immunoblot of pERK1/2 and total (T) ERK after FGFR2b+L6 or KIT+L6 cells were treated with FGF10, SCF, SU, and ISCK.
(G) Immunoblot of pKITY721, pAKT, pERK1/2, and total (T) AKT or ERK1/2 and KIT after epithelia were cultured for 5 min with SCF and/or
FGF10 in the presence of ISCK or SU. Representative blot, n = 3 biological samples.
See also Figure S2.
Stem Cell Reports
KIT/FGFR2b in Salivary GlandsCostimulation with FGF10+SCF for 3 hr increased expres-
sion of Sox10, Myc, Etv4, and Etv5, but not DNp63, above
the level observed with FGF10 alone (Figure 3B). We
show that KIT signaling was essential for this increased
expression, since ISCK reduced expression to a level similar
to that obtained with FGF10 alone. The PI3K inhibitor
LY29052 (which reduces pAKT), but not the PLCg inhibitorStem Cell RU73122, mimicked this effect, suggesting that the posi-
tive regulation by KIT occurs via increased PI3K/AKT
signaling. We confirmed that activation of FGFR2b
signaling upregulated TFs in a MAPK-dependent manner
(Figure S3). Importantly, SCF alone did not have direct ef-
fects on TF gene expression. Furthermore, KIT and FGFR2b
regulate these conserved TF targets in cells that do noteports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 The Authors 607
Figure 3. KIT Signaling Increases Expression of FGFR2b-Dependent Transcriptional Targets
(A) Immunoblot of pSHP2, pAKT, pERK1/2, and total (T) SHP2, AKT, or ERK1/2 at different time points after addition of SCF and/or FGF10.
Graphs represent quantification of a representative blot, n = 3 biological samples.
(B and C) qPCR analysis of gene expression in SMG epithelia (B) or KIT+FGFR2b+L6 cells (C) cultured for 3 hr with SCF and/or FGF10. SMG
epithelia were treated with inhibitors ISCK, LY29052 (LY), or U73122 (U7). Unpaired t test; *p < 0.05, **p < 0.01. Statistics compare
FGF10+SCF with FGF10 alone or with FGF10+SCF+ISCK; n = 3 biological samples.
See also Figure S3.
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KIT/FGFR2b in Salivary Glandsendogenously express the receptors, as was observed with
KIT+FGFR2b+L6 cells stimulated with SCF/FGF10 (Fig-
ure 3C). We conclude that the KIT and FGFR2b signaling608 Stem Cell Reports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 Thepathways converge to increase expression of a conserved
cassette of FGFR2b-dependent TFs during the expansion
of KIT+ endbud progenitors.Authors
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KIT/FGFR2b in Salivary GlandsEndbuds Contain Distinct Populations of KIT+K14+
Distal and KIT+K5+ Proximal Progenitors
In addition to KIT+ endbud progenitors, we previously
identified K5-expressing (K5+) progenitors that are essen-
tial for proximal K19+ duct development (Knox et al.,
2010). Therefore, we characterized the distinct cell types
within the KIT+ population by their keratin (K) expression.
Usually, K5 pairs with K14 (Rock et al., 2009), but in SMG
KIT+ endbuds the basal K14+ cells did not coexpress K5
(Figure 4A). This unexpected observation led us to charac-
terize the progenitor potential of K14+ cells by genetic line-
age tracing. We labeled K14+ cells and their progeny with
GFP using a K14Cre mouse crossed with a RosamTmG re-
porter strain. At P1, we observed GFP expression in
ECAD+ epithelial cells (Figures 4B, S4A, and S4B). The
K14+ progenitors are multipotent, as their progeny
included K5+ ductal cells, Amylase-producing acinar
cells, and smooth-muscle-Actin+ myoepithelial cells (Fig-
ure S4C). FACS analysis showed that KIT+K8+ epithelial
endbud cells are a heterogeneous population of distal
K14+ (14% ± 3%) and proximal K5+ progenitors (10% ±
2%; Figure 4C). Furthermore, proximal K5+ progenitors
and their progeny (K5+K19+ and K19+ cells) were localized
centrally in endbuds and were contiguous with the duct
(Figure 4A). KIT+K8+ cells (56% ± 4%) that did not express
K14, K5, or K19 were located between the basal layer and
central duct cells of the endbud (Figure 4A). We conclude
that the endbud contains two distinct populations of pro-
genitors: a pool of distal KIT+K14+ progenitors and a pool
of proximal KIT+K5+ progenitors.
KIT and FGFR2b Signaling Selectively Expands Distal
Progenitors in the Endbud
Next, we investigatedwhether KITand FGFR2b regulate the
expansion of both distal KIT+K14+ and proximal KIT+K5+
progenitors. Combined FGF10+SCF treatment increased
K14 expression in isolated epithelial endbuds within
24 hr (Figure 4D). Staining for KIT, SOX10, and p63
confirmed that multiple cell layers of K14+ progenitors
were present in the endbud. Conversely, central K19+
ductal cells were reduced as compared with FGF10 treat-
ment alone. Consistent with this, Krt14 and Sox10
increased, whereas Krt19 decreased, with FGF10+SCF
versus FGF10 treatment (Figure S4D). To confirm that KIT
and FGFR2b signaling selectively amplify KIT+K14+ distal
progenitors, we cultured E13 SMGs with FGF10/+ SCF
and did a FACS analysis. Similar to the case with isolated
epithelium, combined KITand FGFR2b signaling expanded
the number of K14+, KIT+, and SOX10+ cells (Figures 4E
and S4E). The KIT+K14+ distal progenitors increased in
number at the expense of KIT+K14 cells (Figure 4F).
This is reflected in the doubling number of all KIT+K14+
cells, including those coexpressing K5 and/or K19: K14+Stem Cell R(K14+K5K19), K14+K5+ (K14+K5+K19), K14+K19+
(K14+K5K19+), and K14+K5+K19+. Immunostaining
validated the FACS data, showing that endbuds contained
more cells expressing K14, SOX10, and KIT (Figure 4G).
Thus, KIT and FGFR2b selectively expand distal KIT+K14+
progenitors, but not proximal KIT+K5+ progenitors or their
K19+ progeny. We also measured proliferation in intact
SMGs and isolated epithelia after FGF10/+ SCF stimula-
tion. FACS analyses showed that the number of prolifer-
ating (Ki67+) and epithelial (ECAD+) SMG cells did not
change with FGF10+SCF treatments (Figure 4E), and there
was no difference in glandmorphology or endbud number
(Figure S4F). In isolated epithelia, SCF alone did not
support survival or proliferation (Figures S4G and S4H).
Since KIT signaling alone did not affect proliferation, we
conclude that selective expansion of KIT+K14+ progenitors
involves combined KIT and FGFR2b signaling for prolifera-
tion and doubling of the cell number.
Expansion of Distal Progenitors Is Essential for
Branching Morphogenesis
We then asked whether distal progenitor cell expansion is
required for branching morphogenesis. We used two loss-
of-function approaches: KitW/W SMGs, which lack KIT
signaling due to a SNP in the W locus (Chabot et al.,
1988), and ISCK treatment of intact SMGs (Figures 5A–
5H). In both E14 KitW/W and ISCK-treated SMGs, we found
a significant reduction in the number of cells expressing
KIT, K14, SOX10, and p63 as determined by protein stain-
ing, FACS analysis, and mRNA expression (Figures 5A, 5B,
5E, S5A, and S5B). Importantly, loss of KIT signaling
reduced branching in cultured ISCK-treated and E14
KitW/W SMGs, which were smaller than KitW/+ and Kit+/+
glands (Figures 5C, 5D, and S5C). Even though E14 KitW/W
SMGs were similar in size to E13 Kit+/+ SMGs, they ex-
hibited reduced branching in culture (Figures 5C, 5D, and
S5C). Notably, this reduction in size was associated with
differentiated ducts with limited proliferative capacity.
Consequently, KitW/W and ISCK-treated SMGs had reduced
numbers of proximal K5+ progenitors and a concomitant
increase in the number of K19+ duct cells (Figures 5A, 5B,
and 5E). Increased expression of Hbegf and Egfr (Figure 5E),
which drive ductal differentiation (Knox et al., 2010) and
reduce proliferation, further supported this finding (Figures
5E and S5B). In sum, loss of KIT signaling drives ductal dif-
ferentiation and reduces branching morphogenesis.
To confirm that the primary defect was due to loss of KIT
function in the epithelium, and not in the mesenchyme or
blood vessels, we cultured both KitW/W and ISCK-treated
wild-type epithelia. Both exhibited reduced growth
compared with the Kit+/+ and DMSO-treated controls (Fig-
ure 5F). As expected, they showed reduced staining for
KIT, CCND1, and K14; increased staining for K19; andeports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 The Authors 609
Figure 4. Combined KIT and FGFR2b Signaling Selectively Expands the Distal KIT+K14+SOX10+ Progenitors
(A) E13 endbud stained for KIT, K14, K8, K5, or K19. Pink cells coexpress K14 and K8 or K5 and K19. Images are 1 mm laser scanning
confocal microscopy (LSCM) sections. Scale bar: 20 mm.
(legend continued on next page)
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KIT/FGFR2b in Salivary Glandsreduced expression of Ccnd1, Sox10, Etv4, Etv5, and Myc
(Figures 5G and 5H). We conclude that reduced epithelial
branching in KitW/Wand ISCK-treated glands was primarily
due to reduced KIT signaling in the epithelium.
We further evaluatedwhether combined KITand FGFR2b
signaling has a conserved role in other organs that require
FGFR2b, such as the lung. The lung, limb, kidney, liver, and
pancreas express transcripts for Kit and Kitl (Figure S5D). At
early stages (E10–E12), both lung epithelia and mesen-
chyme expressed Kit mRNA and protein as determined by
qPCR, in situ analysis, and immunostaining (Figures S5E–
S5G). Lung KIT+ cells are proliferative (CCND1+), express
the progenitor marker SOX9 (Lu et al., 2008), and are
located in FGFR2b+ and inhibitor of DNA binding 2
(ID2)+ endbuds (Rawlins et al., 2009). However, in E14
lung epithelia, KIT protein was not detectable and there
was reduced Kit expression compared with earlier stages
(Figures S5E and S5G). Similar to the case with SMGs, the
loss of KIT signaling in E13 KitW/W lungs resulted in
40% smaller lungs, and there was reduced branching
morphogenesis in E11 lungs cultured with ISCK for 48 hr
(Figures S5H and S5I). This correlated with a reduction in
expression of TFs (Id2, Sox9, Myc, Etv4, and Etv5) in lung
endbuds (Figure S5J). Furthermore, there was reduced
expression of proliferation (Ccnd1) and neuroendocrine
cell markers (Sv2b and Calca), suggesting that KIT signaling
may also impact these cell types. The primary defect in lung
branching was also due to reduced KIT signaling in the
epithelia, as shown by treating E10 lung epithelia with
ISCK (Figure S5K). In gain-of function experiments with
lung epithelia, SCF alone did not affect proliferation (Fig-
ure S5L), but altered TF gene expression when combined
with FGF10. These data suggest that KIT and FGFR2b
signaling expands progenitors by regulating a cassette of
TFs in both SMGs and lungs.
Distal KIT+ Progenitors Communicate with the
Neuronal Niche toMaintain Proximal Progenitors and
Coordinate Ductal Architecture
Since a loss of KIT signaling depletes both distal and prox-
imal progenitors, and proximal progenitors aremaintained(B) Lineage tracing of K14 in P1 SMG from a K14Cre x RosamTmG mouse.
K14 cells (Tomato). Images are 2 mm LSCM sections. Scale bar, 20 mm
(C) FACS analysis of K5, K14, and K19 cells in an epithelial KIT+K8+ c
(D) Staining of K14, KIT, SOX10, p63, and K19 in epithelia cultured f
(E) FACS analysis of KIT, K14, SOX10, K19, ECAD, and Ki67 in E13 SM
biological samples.
(F) FACS analysis of K14-, K5-, and K19-expressing cells in the epit
FGF10/+ SCF. Data are mean ± SEM; n = 3 biological samples.
(G) E13 SMGs cultured for 72 hr in FGF10/+ SCF were stained for K14,
LSCM sections. Scale bar, 20 mm.
See also Figure S4.
Stem Cell Rby innervation (Knox et al., 2010), we hypothesized that
communication occurs between these distinct progenitors
via the neuronal niche. To test this, we analyzed the
parasympathetic innervation in KitW/W and ISCK-treated
SMGs. In both situations, we observed defects in epithelial
innervation and reduced nerve function (Figure 6A). There
was reduced defasciculation (arrowhead), such that fewer
but wider nerve bundles extended toward the endbuds.
Nerves also contained fewer varicosities (Figure 6A, middle
panels), which release neurotransmitters such as acetylcho-
line. Loss of neuronal function in KitW/W and ISCK-treated
SMGs was confirmed by measuring reduced expression of
Tubb3 (an axonal marker), Gfra2 (a parasympathetic
marker), and markers of neuronal acetylcholine function
(vesicular acetylcholine transporter [Slc18a3 or Vacht] and
choline acetyltransferase [Chat]; Figure 6B). Similar reduc-
tions of innervation and similar trends in the reduction
of neuronal function were observed when KIT signaling
was inhibited with ISCK at later stages of development
after branching morphogenesis had occurred (Figures S6A
and S6B). Washout of ISCK resulted in reinnervation,
continued branching morphogenesis, and increased
expression of genes associatedwith neuronal function (Fig-
ures S6B and S6C). These data suggest that maintenance of
epithelial-neuronal communication requires KIT signaling.
To confirm that KIT signaling in KIT+ mesenchymal or
endothelial cells did not influence nerve defasciculation
and proximal K5+ progenitors, we recombined isolated
epithelia from either KitWW or KitWW;K5Venus mice with
control (Kit+/+) mesenchyme, which contains endothelial
and neuronal cells. Recombined SMGs had reduced
epithelial endbud growth and innervation (Figures 6C
and S6D), and depletion of K5+ progenitors occurred in
the KitWW;K5Venus SMGs (Figure S6E) as compared with
control. Taken together, these data confirm that KIT
signaling in distal epithelial progenitors is essential for
functional innervation and maintenance of proximal K5+
progenitors.
Since loss of KIT signaling affects K5+ proximal progeni-
tors indirectly via the nerves, we predicted that we could
rescue the K5+ cells from ISCK treatment with CCh andK14 progeny cells (GFP), endogenous K14 (red and yellow), and non-
.
ell population of E13 SMGs. Mean ± SEM; n > 3 biological samples.
or 24 hr in FGF10/+ SCF. Scale bar, 20 mm.
Gs cultured for 72 hr in FGF10/+ SCF. Data are mean ± SEM; n > 3
helial K8+KIT+ cell population in E13 SMGs cultured for 72 hr in
SOX10, and K19, or KIT, ECAD, and Perlecan (PLN). Images are 1 mm
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Figure 5. Loss of Epithelial KIT Signaling Reduces Branching Morphogenesis by Depleting Both K14+ and K5+ Progenitors
(A) Staining for K14, K5, and K19 in E14 SMG endbuds from Kit+/+ and KitW/Wmice or E13 SMGs cultured for 72 hr with DMSO or ISCK. Images
are 1 mm LSCM sections. Scale bar, 20 mm.
(B) FACS analysis of KIT, K14, SOX10, K5, K19, Ki67, and ECAD in E13 SMGs cultured with DMSO (Cont) or ISCK. Data are mean ± SEM; n > 3
biological samples.
(C) E14 and E13 SMGs from Kit+/+, KitW/+, and KitW/W embryos cultured for 24 hr, and E13 SMGs cultured in DMSO (Control) or ISCK for 72 hr.
Scale bar, 200 mm.
(D) Endbud number from (C). Data are normalized to 0 hr and E14 Kit+/+ or Control. Unpaired t test, ***p < 0.01, ISCK versus DMSO, KitW/+
and KitW/W versus Kit+/+, and E13 versus KitW/W. Unpaired t test, ***p < 0.01; n > 3 biological samples.
(legend continued on next page)
612 Stem Cell Reports j Vol. 1 j 604–619 j December 17, 2013 j ª2013 The Authors
Stem Cell Reports
KIT/FGFR2b in Salivary Glands
Stem Cell Reports
KIT/FGFR2b in Salivary GlandsHBEGF, which maintain K5+ progenitors (Knox et al.,
2010). The addition of CCh and HBEGF to ISCK-treated
SMGs maintained K5+ cells, but K14+ proximal progeni-
tors were not rescued (Figures 6D and S6F). There was
also no increase in branchingmorphogenesis or expression
ofKrt14,Kit, and Sox10 (Figure S6F). These data suggest that
coordination of the organ’s architecture requires KIT-medi-
ated expansion of K14+ distal progenitors.
We then hypothesized that KIT+ cells secrete neurotro-
phic factors that promote innervation and neuronal
function. We recently identified that neurturin (NRTN) is
produced by SMG epithelium and is important for
neuronal survival (Knox et al., 2013). KitW/W and ISCK-
treated SMGs showed reduced Nrtn expression compared
with controls (Figure 6B). Furthermore, FACS-sorted
epithelial KIT+FGFR2b+ cells from E13 SMGs had 3-fold
more Nrtn expression than KIT cells (Figure S6G). In
addition, we confirmed that this occurred both in KitW/W
lungs and in control E11 lungs treated with ISCK, in which
we also observed reduced innervation and varicosities
(Figure S6H). Importantly, in both situations there was
reduced Nrtn, Tubb3, and Vacht expression (Figure S6H).
There was also reduced Gfra2 in KitW/W lungs and reduced
Chat expression with ISCK treatment. Thus, the reduction
in neuronal gene expression is likely secondary to the
reduction in NRTN. We conclude that the production
of neurotrophic factors by distal KIT+ progenitors is a
conserved mechanism to support the neuronal niche dur-
ing organogenesis.
KIT Signaling in a Rare Population of Adult
KIT+FGFR2b+ Progenitors Maintains Epithelial-
Neuronal Communication during Homeostasis
Since adult SMG epithelial KIT+ cells (Lombaert et al.,
2008) and lung KIT+ cells (Kajstura et al., 2011) were used
for regeneration, we sought to determine whether our
findings from organogenesis were conserved during adult
tissue homeostasis. Immunostaining of the adult SMG
revealed that KIT+ cells were localized in intercalated ducts
(IDs; Figure 7A), which harbor progenitor cells based on
label-retaining assays (Man et al., 2001) and are in close
proximity to differentiated Aquaporin5+ acinar cells
(Figure 7B). Adult mouse lungs exhibited abundant(E) qPCR analysis of E14 Kit+/+ and KitW/W SMGs, and SMGs cultured for 7
or Control (dotted line), respectively, and Rps29. Unpaired t test, *p
(F) Isolated KitW/W epithelia and E13 epithelia treated with ISCK for 4
Scale bar, 20 mm.
(G) Isolated epithelia cultured with ISCK for 48 hr have reduced stainin
of 1 mm section through endbud.
(H) Gene-expression profile of Kit+/+ and KitW/W or DMSO and ISCK-trea
Rps29. Unpaired t test, *p < 0.05, **p < 0.01, ***p < 0.001; n = 3 b
See also Figure S5.
Stem Cell RKIT+Vimentin+ or KIT+CD31+ blood vessels, with only
rare epithelial KIT+ECAD+ or K18+ cells detected (Fig-
ure S7A). Similar to what was observed during organogen-
esis, adult SMG KIT+ progenitors were proliferative
(CCND1+) (Figures 7C and 7F) and expressed FGFR2b on
their cell membrane (Figures 7D and 7F). To compare their
expression with that of embryonic KIT+ cells, we FACS
sorted adult SMG epithelial LIN-EPCAM+KIT+FGFR2b+
cells, termed KIT+FGFR2b+. FGFR2b was expressed on
fewer KIT+ cells in the adult SMG (23% ± 3%, green peak;
Figure 7E) compared with KIT+ cells in E13 SMGs (90% ±
4%, green peak; Figure 7E). Since KIT+ cells account for
3% of epithelial cells in the adult gland (Lombaert et al.,
2008), adult KIT+FGFR2b+ cells are a rare population of
0.6% ± 0.2%. Intriguingly, qPCR analysis of adult
KIT+FGFR2b+ sorted cells revealed a striking similarity to
embryonic KIT+ progenitors, with Etv4, Sox10, Ccdn1,
and Nrtn being highly expressed compared with
KIT+FGFR2b cells (Figure 7F). Therefore, we predicted
that KIT and FGFR2b signaling in adult ID epithelial cells
might also maintain communication with nerves. Since
KitW/W is embryonic lethal, we cultured adult wild-type
SMG explants for 3 days in the presence of ISCK. As pre-
dicted, neuronal innervation was affected (Figure 7G) and
K5 and K14 staining was reduced along with an increase
in ductal K19+ cells (Figure 7H). Accordingly, ISCK reduced
expression of Tubb3, Krt5, Krt14, Kit, and Ccnd1 (Figure 7J).
Conversely, adding FGF10 and SCF increased cell prolifera-
tion and Ccnd1 (Figures 7I and 7J). Taken together, these
data indicate that during organ homeostasis, KIT signaling
also maintains the ductal architecture via communication
among multiple epithelial progenitors and their niches.
Finally, we confirmed that a similar KIT+FGFR2b+ cell
population occurs in human salivary glands (Figure 7K).
Human SMG KIT+ cells are located in IDs and excretory
ducts (EDs). Although many KIT+ cells expressed SOX10
(Figure S7B), only a rare population of KIT+ cells coex-
pressed FGFR2 (Figure 7K). Surprisingly, we also detected
KIT expression on acinar cells, which may make them
potentially responsive to KIT signaling as well, although
they were not FGFR2+. The working model presented in
Figure 7L shows that mesenchymal-derived SCF and
FGF10 expand KIT+FGFR2b+ distal progenitors that2 hr with DMSO (Control) or ISCK. Data were normalized to E14 Kit+/+
< 0.05, **p < 0.01, ***p < 0.001; n = 3 biological samples.
8 hr undergo less epithelial morphogenesis than control epithelia.
g for KIT, CCND1, and K14, and increased K19 staining. LCSM image
ted epithelia. Data were normalized to control (DMSO or Kit+/+) and
iological samples.
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Figure 6. KIT Signaling in Distal Epithelial Progenitors Is Essential for Epithelial-Neuronal Communication and Maintenance of
Proximal K5+ Progenitors
(A) Staining for nerves (TUBB3) and epithelium (PNA) in E14 Kit+/+ and KitW/W SMGs and E13 SMGs cultured for 72 hr with
DMSO (Control) or ISCK. White box in upper panels is shown in middle panels. Arrowheads represent axons, arrows indicate varicosities.
Scale bars, 200 mm (upper and lower panels) and 20 mm (middle panel). Images are 1 mm LSCM sections. Graphs show nerve
area (area of nerves/area of epithelia) and varicosities (number of varicosities per area of TUBB3). Mean ± SEM. Unpaired t test,
**p < 0.05.
(B) qPCR analysis of genes that are markers of neuronal function in E14 Kit+/+ and KitW/W SMGs, and in E13 SMGs cultured for 72 hr with
DMSO (Control) or ISCK. Data were normalized to Control (dotted line) or E14 Kit+/+, respectively, and Rps29. Unpaired t test, *p < 0.05,
**p < 0.01, ***p < 0.001; n = 3 biological samples.
(legend continued on next page)
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KIT/FGFR2b in Salivary Glandscoordinate organ architecture by establishing communica-
tion between multiple niches and proximal progenitors.DISCUSSION
Here, we propose that combined KIT and FGFR2b signaling
regulates epithelial progenitor expansion. We identify
an interaction between KIT and FGFR2b signaling path-
ways that converges to upregulate a conserved group of
FGFR2b-dependent TFs and expand distal progenitors.
These progenitors further communicate with the neuronal
niche to direct proximal progenitors to form ducts. These
interactions are maintained during adult organ homeosta-
sis, and exist in human organs. Our findings may have
implications for regenerative medicine because they
demonstrate that both KIT and FGFR2b signaling and
communication among multiple cell types are necessary
for organogenesis.
We propose that a similar conserved mechanism occurs
in other organs, because FGFR2b signaling is required to
initiate development of mammary, pituitary, and thyroid
glands, as well as the kidney, pancreas, and prostate (Lin
et al., 2007; Mailleux et al., 2002; Ohuchi et al., 2000).
Similarly, KIT is expressed in these organs and is essential
for kidney and prostate development (La Rosa et al., 2008;
Leong et al., 2008; Li et al., 2007; Schmidt-Ott et al., 2006;
Ulivi et al., 2004). Although previous studies have shown
that FGFR2b signaling induces progenitor survival and
proliferation (Bhushan et al., 2001; Ohuchi et al., 2000),
we now demonstrate that it is a key upstream driver that
induces distal KIT+ progenitor expansion. FGFR2b
signaling achieves this by upregulating the KIT pathway
to maintain KIT+-responsive progenitors. This is a critical
event because combined KIT and FGFR2b signaling path-
ways converge at the transcriptional level to upregulate
the expression of a conserved cassette of FGFR2b-depen-
dent TFs in KIT+ progenitors. Distal progenitors of other
organs, such as the pancreas (Kobberup et al., 2007) and
limb (Zhang et al., 2009), express ETV4 and ETV5, which
are part of this conserved TF cassette. Our experiments
with L6 rat myoblasts also suggest that conserved TFs are
upregulated when KIT and FGFR2b are overexpressed in
cells where they are not normally present, and that for
each cell type additional TFs may provide a cell-type-spe-
cific response.(C) Recombination of Kit+/+ or KitWW epithelia with Kit+/+mesenchyme
innervation. SMGs were stained for nerves (TUBB3) and ECAD. White bo
respectively.
(D) Staining of K5, K14, and K19 in endbuds from SMGs cultured with D
sections. Scale bar, 20 mm.
See also Figure S6.
Stem Cell RWe also propose that the KIT/FGFR2b pathway likely in-
tegrates with other signaling pathways to direct progenitor
expansion. For example,WNTsignaling has been proposed
to be a master regulator of lung development (Rajagopal
et al., 2008). Yet, our data suggest that WNT and KIT/
FGFR2b can affect distal progenitors in different ways.
The specific loss of WNT7b did not alter the number of
Sox9 or SOX9+ cells in lungs, whereas loss of KIT signaling
reduced Sox9 in lung endbuds. In contrast to WNT
signaling, KITdoesnot directly influenceCCND1-mediated
proliferation, and although lung development is arrested in
FGFR2b/ mice, it is only reduced in b-Catenin/ mice
(Mucenski et al., 2003; Shu et al., 2005). Itwill be interesting
to determine whether the neuronal niche is affected in
WNT-depleted mice.
Prior to this work, we did not fully understand how
epithelial progenitors communicate with their surround-
ing niche during organogenesis (Bryant and Mostov,
2008; Hogan, 1999). Here, we propose that a key mecha-
nism is distal progenitor expansion, since these cells pro-
duce critical neurotrophic signals to communicate with
the neuronal niche to regulate proximal progenitors. Neu-
rturin is also produced by distal progenitors in the kidney
(Davies et al., 1999) and is found in the prostate, pituitary
gland, and pancreas (Golden et al., 1999). It is not known
whether KIT+ cells secrete neurotrophic factors in these
organs.
Previous studies have shown that paracrine and auto-
crine morphogenic gradients control branching morpho-
genesis, and a number of models propose the existence of
iterative positive and negative unidirectional cues between
the epithelium and mesenchyme or within the epithelial
lineage (Bryant and Mostov, 2008; Gjorevski and Nelson,
2011; Hogan, 1999; Hsu and Fuchs, 2012). These studies
provided valuable insights into organogenesis, but focused
on communication from a single cell type. Progenitors
in vivo must interpret signals from multiple cell types in
their surrounding microenvironment during organogen-
esis. Our work has implications for regenerative medicine
and the bioengineering of tissues, which may require mul-
tiple progenitor cell types to generate branching organs.
Also, our findings will inform efforts to expand epithelial
progenitors in vitro, which will be critical in clinical set-
tings where small numbers of progenitors from biopsies
could be expanded with reagents that target FGFR2b, KIT,
and the neuronal niche. We propose that using progenitorcultured for 72 hr shows that loss of epithelial KIT signaling reduces
x in upper panel is shown in lower panel. Scale bars, 200 and 20 mm,
MSO (Control), ISCK, and/or CCh and HBEGF. Images are 1 mm LCSM
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KIT/FGFR2b in Salivary Glandstransplants with factors that preserve nerves will improve
regeneration of damaged organs. For instance, nerves
may facilitate the production of insulin (Rossi et al.,
2005) after grafting of beta-progenitors to treat diabetic
neuropathy and pancreatitis (Melton, 2011), or enhance
lung repair after progenitor transplants (Rock and Hogan,
2011).
It has been proposed that tumors and organs are similar
in terms of the complexity of cell types, microenviron-
ments, and signaling networks involved in these compo-
nents (Hanahan and Weinberg, 2011). The clonal nature
of cancer means that targeting a single RTK may provide
selective pressure for resistant tumor clones (Nik-Zainal
et al., 2012). It is also possible that an activating KIT or
FGFR2 mutation in an FGFR2b- or KIT-expressing tumor,
respectively, may expand a dominant tumor clone and
amplify downstream responses. Thus, by targeting KIT
and FGFR2b, and/or the signals between the progenitors
and their niches, wemay be able to target tumorsmore effi-
ciently. In conclusion, a clear resolution of the signaling
pathways and communication among multiple cell types
that are representative of the endogenous microenviron-
ment during organogenesis and homeostasis provides
insight into tumor biology and a framework to direct ther-
apeutic organ regeneration.EXPERIMENTAL PROCEDURES
Mouse Lines, Breeding, Genotyping, and Lineage
Tracing
All protocols involving mice (Supplemental Experimental Proce-
dures) were approved by the NIH ACUC. Culture of Mo7e and L6
cells, and staining of human biopsies are described in the Supple-
mental Experimental Procedures.Figure 7. KIT Signaling Regulates Epithelial-Neuronal Commu
KIT+FGFR2b+ Cells that Are Present in Human SMGs
(A–D) Staining of KIT, ECAD, PLN, Aquaporin 5 (AQP5), CCND1, FGFR2b,
(a). Scale bar, 10 mm. Graph represents the protein intensity of KIT a
(E) Histogram of FACS analysis showing the total number of FGFR2b+ c
adult SMGs. Data are mean ± SEM; n > 3 biological samples. Gray are
(F) qPCR analysis of FACS-sorted adult SMG epithelial LIN-EPCAM+KIT+
to KIT-FGFR2b cells and Rps29. Unpaired t test, *p < 0.05, **p < 0
(G and H) Adult SMG explants cultured for 3 days with ISCK. Staining o
in (H). Images are 10 mm LCSM sections. Scale bars: 20 mm.
(I) Adult SMG explants cultured for 3 days ± FGF10+SCF were stained fo
(J) qPCR analysis of adult SMG explants cultured in basal media (Con
Control or DMSO, and Rps29. Unpaired t test, *p < 0.05, **p < 0.01,
(K) Staining of KIT, ECAD, DAPI, and FGFR2 in human SMGs. Image
striated duct.
(L) Working model. Multicellular communication initiated by combine
during organogenesis and adult homeostasis.
See also Figure S7.
Stem Cell REx Vivo Organ Culture
We performed fetal and adult intact organ and mesenchyme-free
epithelia culture of SMG or lung in the presence of different
growth factors and/or inhibitors as described in the Supplemental
Experimental Procedures.
qPCR
Real-time qPCRwas performed as previously described (Knox et al.,
2013). cDNAs were generated and amplified to determine fold
changes in expression by normalizing to the housekeeping gene
Rps29. The generation of single amplicon products was confirmed
by melt curve analysis.
Immunofluorescence Analysis and FACS
We performed whole-mount immunofluorescence as described in
the Supplemental Experimental Procedures. For FACS, single-cell
suspensions of SMGs were analyzed on either a BD Calibur or an
LSRII, and sorted on a BD Aria sorter (see Supplemental Experi-
mental Procedures). Negative cell populations were used as
controls.
In Situ Hybridization
Digoxigen-11-UTP-labeled single-stranded RNA probes were pre-
pared using the DIG RNA labeling kit (Roche Applied Science)
according to the manufacturer’s instructions.
Western Blot Analysis
Protein lysates were resolved on Tris gels, transferred to mem-
branes, probed with antibodies, and visualized with West Dura
reagent as described in detail in the Supplemental Experimental
Procedures.
Statistical Analysis
Experiments were performed with at least three biological repli-
cates. To determine significance between two groups, comparisons
were made using Student’s t test. Analysis of multiple groups wasnication during Homeostasis in a Rare Population of Adult
and DAPI in adult mouse SMGs. Arrows indicate IDs near acinar cells
nd FGFR2b through an ID cell. BF, bright field.
ells within the epithelial (EPCAM+, epi) KIT+ population in E13 and
a, KIT+FGFR2b cells; green area, KIT+FGFR2b+ cells.
FGFR2b+ and LIN-EPCAM+KIT-FGFR2b cells. Data were normalized
.01; n = 3 biological samples.
f ECAD, nerves (TUBB3), and DAPI in (G), and K14, K19, K5 and DAPI
r CCND1 and DAPI. Images are 1 mm LSCM section. Scale bar, 20 mm.
trol), FGF10+SCF, DMSO, or ISCK for 72 hr. Data were normalized to
***p < 0.001; n = 3 biological samples.
s are 1 mm LSCM section. Scale bars, 20 mm. a, acinar cells; SD,
d KIT and FGFR2b signaling establishes the branching architecture
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KIT/FGFR2b in Salivary Glandsperformed by one-way ANOVA. For statistical tests, p < 0.05 was
considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and seven figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2013.10.013.
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